Results 81 to 90 of about 756 (131)

Medical management of primary hyperparathyroidism. [PDF]

open access: yesArch Endocrinol Metab, 2022
Bandeira F   +3 more
europepmc   +1 more source

Bone diseases and the COVID-19 pandemic. [PDF]

open access: yesArch Endocrinol Metab, 2022
Bandeira F, Bilezikian JP.
europepmc   +1 more source

Kinetics of neutralizing and binding antibody responses following Zika virus infection during pregnancy: A nested analysis of participants from the microcephaly epidemic research group (MERG) and Zika in infants and pregnancy (ZIP) cohorts. [PDF]

open access: yesVirus Res
Silva MVM   +12 more
europepmc   +1 more source

Tragedias

open access: yes, 2009
Formato PDF. 170 p.Vigoroso en sus planteamientos, audaz en su lenguaje plagado de metáforas que crean un mundo de imágenes maravilloso rebosante de pasión que muestran del principio al fin sus siete obras conservadas: Los persas, Los siete contra Tebas,
Esquilo
core  

Real-world characterization of PD-L1 expression in patients with advanced esophagogastric adenocarcinoma in Spain. [PDF]

open access: yesClin Transl Oncol
Jimenez-Fonseca P   +26 more
europepmc   +1 more source

Treatment and Outcomes in Advanced Gastroesophageal Adenocarcinoma in the Pre-Immunotherapy Era Based on the Spanish AGAMENON-SEOM Registry. [PDF]

open access: yesCancers (Basel)
Jimenez-Fonseca P   +19 more
europepmc   +1 more source

Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry. [PDF]

open access: yesJ Cancer Res Clin Oncol, 2023
Valcarcel S   +28 more
europepmc   +1 more source

Does perioperative FLOT increase cure rates in resectable esophageal adenocarcinoma? A mixture cure model analysis. [PDF]

open access: yesBr J Cancer
Mateos L   +28 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy